SUN PHARMACEUTICAL INDUSTRIES INC FDA Inspection Record

FEI 3013472760 · Inspections, Form 483s, warning letters and import refusals

SUN PHARMACEUTICAL INDUSTRIES INC is an FDA-inspected facility (FEI 3013472760) located in Princeton, NJ, US. RegDataLab tracks 13 FDA inspections and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Dec 12, 2024: No Action Indicated (NAI)
Inspections on record
13 (1 OAI, 5 VAI, 7 NAI)
Last OAI inspection
Apr 28, 2010
Warning letters
1 listed by FDA for this FEI, latest Aug 25, 2010
Recalls as the recalling firm
71, latest Oct 21, 2026
Import refusals
1

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Showing the 10 most recent of 13 inspections. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Dec 12, 2024No Action Indicated (NAI)No citations listed
Aug 10, 2022No Action Indicated (NAI)No citations listed
Mar 8, 2019No Action Indicated (NAI)No citations listed
Sep 18, 2018No Action Indicated (NAI)No citations listed
Mar 9, 2018Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))
Calibration/Inspection/Checking not done (21 CFR 211.68(a))
Packaging line inspection after use (21 CFR 211.130(e))
and 4 more
Mar 20, 2017Voluntary Action Indicated (VAI)Identification of Persons Performing Significant Steps (21 CFR 211.188(b)(11))
Nov 20, 2015No Action Indicated (NAI)No citations listed
Aug 27, 2015Voluntary Action Indicated (VAI)Late submission of 15-day report (21 CFR 314.80(c)(1)(i))
Submission of report follow-up (21 CFR 314.80(c)(1)(ii))
Jul 15, 2015Voluntary Action Indicated (VAI)No citations listed
May 16, 2013Voluntary Action Indicated (VAI)No citations listed

Recalls

Showing the 10 most recent of 71 recalls. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Oct 21, 2026Class IID-0174-2027Lisdexamfetamine Dimesylate Capsules 40 mg, 100-count bottle, Rx Only, Manufactured by…
Failed Dissolution Specifications
Sep 25, 2026Class IIID-0033-2027Tretinoin Cream USP, 0.05%, 45g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc… and 2 more products
Failed Impurities/Degradation Specifications
Sep 14, 2026Class IID-0872-2026Nystatin Cream, USP, 100,000 units/g, 15 g (NDC 51672-1289-1) and 30 g (NDC 51672-1289-2)…
Failed Stability Specifications
Aug 3, 2026Class IID-0770-2026Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro…
CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
Jun 17, 2026Class IID-0628-2026Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets, Mfd.by: Taro Pharmaceutical Industries…
Labeling: Label Mix-up: Bottle labeled Perampanel 6 mg tablets contained 10mg Perampanel CIII tablets
Jun 1, 2026Class IIID-0654-2026Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle…
Failed Impurities/Degradation Specifications
May 29, 2026Class IID-0607-2026Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5…
Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and…
May 22, 2026Class IID-0598-2026Xyvona (levorphanol tartrate tablets), 2mg, 100 Tablets, Rx only, Forte BioPharma… and 1 more product
Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the…
May 12, 2026Class ID-0580-2026DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials…
Presence of Particulate matter: Particulate matter identified as glass.
Mar 25, 2026Class IID-0475-2026Fluocinonide, USP, 0.05% Cream, 15g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc… and 2 more products
Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

FDA record score

100 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. The records below add up to 139; the score stops at 100.

Counted on Nov 16, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

55 records behind this number
RecordDatePoints x age weightAdds
Class I recall D-0580-2026, this FEI as the recalling firmMay 12, 202615 x 115
Class II recall D-0174-2027, this FEI as the recalling firmOct 21, 20264 x 14
Class II recall D-0872-2026, this FEI as the recalling firmSep 14, 20264 x 14
Class II recall D-0770-2026, this FEI as the recalling firmAug 3, 20264 x 14
Class II recall D-0628-2026, this FEI as the recalling firmJun 17, 20264 x 14
Class II recall D-0607-2026, this FEI as the recalling firmMay 29, 20264 x 14
Class II recall D-0598-2026, this FEI as the recalling firmMay 22, 20264 x 14
Class II recall D-0475-2026, this FEI as the recalling firmMar 25, 20264 x 14
Class II recall D-0342-2026, this FEI as the recalling firmJan 27, 20264 x 14
Class II recall D-0144-2026, this FEI as the recalling firmOct 28, 20254 x 14
Class II recall D-0658-2025, this FEI as the recalling firmSep 3, 20254 x 14
Class II recall D-0574-2025, this FEI as the recalling firmAug 5, 20254 x 14
Class II recall D-0516-2025, this FEI as the recalling firmJun 16, 20254 x 14
Class II recall D-0249-2025, this FEI as the recalling firmFeb 6, 20254 x 14
Class II recall D-0597-2024, this FEI as the recalling firmJul 9, 20244 x 0.62.4
Class II recall D-0582-2024, this FEI as the recalling firmJul 2, 20244 x 0.62.4
Class II recall D-0493-2024, this FEI as the recalling firmApr 19, 20244 x 0.62.4
Class II recall D-0368-2024, this FEI as the recalling firmMar 4, 20244 x 0.62.4
Class II recall D-0350-2024, this FEI as the recalling firmFeb 5, 20244 x 0.62.4
Class II recall D-0263-2024, this FEI as the recalling firmJan 18, 20244 x 0.62.4
Class II recall D-0150-2024, this FEI as the recalling firmDec 4, 20234 x 0.62.4
Class II recall D-0083-2024, this FEI as the recalling firmOct 20, 20234 x 0.62.4
Class II recall D-0940-2023, this FEI as the recalling firmJul 13, 20234 x 0.62.4
Class II recall D-0914-2023, this FEI as the recalling firmJul 10, 20234 x 0.62.4
Class II recall D-0891-2023, this FEI as the recalling firmMay 30, 20234 x 0.62.4
Class II recall D-0761-2023, this FEI as the recalling firmMay 9, 20234 x 0.62.4
Class II recall D-0869-2023, this FEI as the recalling firmMay 3, 20234 x 0.62.4
Class II recall D-0262-2023, this FEI as the recalling firmJan 13, 20234 x 0.62.4
Class II recall D-0085-2023, this FEI as the recalling firmDec 1, 20224 x 0.62.4
Class II recall D-0024-2023, this FEI as the recalling firmOct 18, 20224 x 0.62.4
Class II recall D-0068-2023, this FEI as the recalling firmJul 25, 20224 x 0.62.4
Class II recall D-1291-2022, this FEI as the recalling firmJun 27, 20224 x 0.62.4
Class II recall D-1190-2022, this FEI as the recalling firmJun 21, 20224 x 0.62.4
Class II recall D-1154-2022, this FEI as the recalling firmJun 10, 20224 x 0.62.4
Class II recall D-1153-2022, this FEI as the recalling firmJun 3, 20224 x 0.62.4
Class II recall D-1155-2022, this FEI as the recalling firmJun 3, 20224 x 0.62.4
Class II recall D-1176-2022, this FEI as the recalling firmJun 3, 20224 x 0.62.4
Class II recall D-1143-2022, this FEI as the recalling firmMay 6, 20224 x 0.62.4
Class II recall D-0578-2022, this FEI as the recalling firmFeb 7, 20224 x 0.62.4
Inspection classified VAIMar 9, 20186 x 0.251.5
Inspection classified VAIMar 20, 20176 x 0.251.5
Class II recall D-0230-2022, this FEI as the recalling firmOct 25, 20214 x 0.251
Class II recall D-0361-2022, this FEI as the recalling firmOct 22, 20214 x 0.251
Class II recall D-0703-2021, this FEI as the recalling firmJul 29, 20214 x 0.251
Class II recall D-0372-2021, this FEI as the recalling firmMay 4, 20214 x 0.251
Class II recall D-0334-2021, this FEI as the recalling firmMar 31, 20214 x 0.251
Class II recall D-0320-2021, this FEI as the recalling firmMar 15, 20214 x 0.251
Class II recall D-0002-2021, this FEI as the recalling firmSep 23, 20204 x 0.251
Class II recall D-0787-2020, this FEI as the recalling firmJan 14, 20204 x 0.251
Class II recall D-0659-2020, this FEI as the recalling firmDec 26, 20194 x 0.251
Inspection classified VAIAug 27, 201510 years or older, so it adds no points0
Inspection classified VAIJul 15, 201510 years or older, so it adds no points0
Inspection classified VAIMay 16, 201310 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsAug 25, 201010 years or older, so it adds no points0
Inspection classified OAIApr 28, 201010 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing SUN PHARMACEUTICAL INDUSTRIES INC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check SUN PHARMACEUTICAL INDUSTRIES INC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
SUN PHARMACEUTICAL INDUSTRIES INC
Location
Princeton, NJ (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.